Delivery Order SPE2DB24D2011-SPE2DB25FBQYZ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,404.09 to AmerisourceBergen Drug Corp for Carvedilol ER 20 mg capsules (30-count units) on August 26, 2025, with an ultimate completion date of August 27, 2025. This firm fixed price, non-set-aside contract will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for Carvedilol ER 20 mg capsules (30-count) with a ceiling value of $3,744.24. This is a firm fixed-price, non-competitive delivery order completed on September 12, 2025, with an ultimate completion date of September 15, 2025. The place of performance is AmerisourceBergen's Corporate Office in Conshohocken, PA. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 30-day supply of Carvedilol ER 20 mg capsules, valued at $12,421.40 under a firm fixed price contract. The award, made on May 22, 2025, with an ultimate completion date of May 23, 2025, represents a non-set-aside competitive award. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,586.69 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 40 mg capsules (30-count units) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price, non-set-aside contract was performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $3,056.22 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 20 mg capsules (30-count) on August 19, 2025, with completion targeted for August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,109.28 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 20 MG capsules (30-count units) on September 12, 2025, with completion scheduled for September 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's significantly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 20 mg capsules (30-count units) under a firm fixed-price contract valued at $15,959.88. The award, issued on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,255.74 for Carvedilol ER 20 mg capsules (30-count) with an ultimate completion date of August 28, 2025. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order valued at $3,159.65 to AmerisourceBergen Drug Corp for Carvedilol ER 10 mg capsules (30-count) on August 5, 2025, with an ultimate completion date of August 6, 2025. This is a firm fixed-price contract with no set-aside designation, meaning it was competitively awarded. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $20,485.64 for Carvedilol ER 20 mg capsules (30-count) by the Defense Logistics Agency's Medical Supply Chain. This competitive, firm fixed-price award was issued on August 8, 2025, with an ultimate completion date of August 11, 2025. The contract carries no set-aside designation, indicating it was awarded through open competition. The place...
- SPE2DB24D2011Indefinite Delivery Contract
- SPE2DB24D2011-SPE2DB25FBQYZDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,282.62 to AmerisourceBergen Drug Corp for Carvedilol ER 10 mg capsules (30-count) on May 30, 2025, with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a prime vendor agreement valued at $999,999,999.00 and extending through December 2026, which enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies. The company's selection as a DLA prime vendor reflects its capability to meet federal procurement requirements through open competition and its demonstrated versatility in fulfilling diverse federal medical supply needs across multiple therapeutic domains. This delivery order for Carvedilol ER—a cardiac medication—represents one of numerous pharmaceutical deliveries the company provides to support military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 5/30/25 |